The incidence and prevalence of heart failure with preserved ejection fraction (HFpEF)
continue to rise in tandem with the increasing age and burdens of obesity, sedentariness …

Heart failure with preserved ejection fraction (HFPEF) is increasing in prevalence with the
aging of the population, and morbidity and mortality rates are comparable to that of heart …

The majority of older patients who develop heart failure (HF), particularly older women, have
a preserved left ventricular ejection fraction (HFpEF). Patients with HFpEF have severe …

Heart failure with preserved ejection fraction (HFpEF), a major public health problem that is
rising in prevalence, is associated with high morbidity and mortality and is considered to be …

Heart failure with preserved ejection fraction (HFpEF) has grown to become the dominant
form of heart failure worldwide, in tandem with ageing of the general population and the …

Heart failure (HF) is a clinical syndrome of diverse etiologies and can be associated with
preserved, reduced, or mid-range ejection fraction (EF). In the community, heart failure with …

Abstract In the USA, 5.7 million Americans≥ 20 years have heart failure (HF) and heart
failure preserved ejection fraction (HFpEF) accounts for at least 50% of all hospital …

Over the past 2 decades, the syndrome of heart failure with preserved ejection fraction
(HFpEF) received a lot of attention. 1–19 However, little therapeutic progress was made. 20 …

Heart failure (HF) is one of the largest drivers of morbidity and health care expenditure in the
world and continues to increase in prevalence at an alarming rate. Most of this increasing …

Approximately half of all patients with heart failure (HF) have a preserved ejection fraction,
and the prevalence is growing rapidly given the aging population in many countries and the …